News

You can now register for the 2018 CADTH Symposium! To ensure a balanced mix of attendees, we use a two-step registration process. Step 1: Request to Register — Click on the “Request to Register” link and complete the form Step 2: Complete Your Registration — Our Event Managers will send you the…
A draft report on Dental Amalgams Compared With Resin Composites is now available for feedback from all interested stakeholders. Project Call for Feedback Feedback Due By Dental Amalgams Compared With Resin Composites 2018-01-31 2018-02-14 Consultation Document Product Type Submit Stakeholder…
In 2017, CADTH began preliminary work on a Therapeutic Review to assess new third-line drug therapies for type 2 diabetes and provide recommendations on their optimal use. The drugs included in this review included dipeptidyl peptidase-4 inhibitors, glucagon-like peptide-1 analogues, and sodium-…
A draft report on Optimal Strategies for the Diagnosis of Acute Pulmonary Embolism is now available for feedback from all interested stakeholders. Project Call for Feedback Feedback Due By Optimal Strategies for the Diagnosis of Acute Pulmonary Embolism 2018-01-22 2018-02-06 Consultation Document…
A draft report on Canadian Medical Imaging Inventory (CMII) is now available for feedback from all interested stakeholders. Project Call for Feedback Feedback Due By Canadian Medical Imaging Inventory (CMII) 2018-01-19 2018-02-02 Consultation Document Product Type Submit Stakeholder Feedback…
A draft report on Public Dental Programs and Reimbursement for Dental Restorative Procedures is now available for feedback from all interested stakeholders. Project Call for Feedback Feedback Due By Public Dental Programs and Reimbursement for Dental Restorative Procedures 2018-01-22 2018-02-05…
Given the theme of the 2018 CADTH Symposium ― Managing Health Technologies: Supporting Appropriate, Affordable, and Accessible Care ― which relates so directly to patients, CADTH is very pleased that our conference is once again officially accredited by Patients Included. The annual CADTH Symposium…
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
A Statement from Dr. Brian O’Rourke, President and CEO In November 2016 I represented CADTH at the two-day Opioid Summit, joining many others to discuss Canada’s response to the escalating opioid crisis and make a formal commitment to the Joint Statement of Action to Address the Opioid Crisis. I…
CADTH has received the following drug submission(s) and/or notice(s) of pending submission(s). If you are interested in providing patient input, please click on “Submit.” For information about the patient input process or for additional instructions, please see the Patient Input page of our website…
See CDR Update 132 for important news and information regarding the CADTH Common Drug Review.
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.